Maren Bohne, NP
Nurse Practitioner · Alamo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 3 carriers
- Office
- 1
- Since medical school
- 10 years
- Johns Hopkins University School of Medicine, 2016
Offices
1 location · Bass Medical Group · 292 clinicians in this group
Hospitals listed: Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
5 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Maren Bohne’s office at (925) 932-6330 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$5,036
Medicare paid this office $5,036 for 34 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 12 | $1,886 | $157 |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 1-10 | None |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Replacement of knee joint, both sides of knee | 16 | – | – | – | – | 12 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
34 Original Medicare patients in 2024. Average age 75 · Under 65 0% · 85 and older 0% · Women 53% · Health risk score 1.04. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 41% · Depression 41% · Chronic kidney disease 35%.
The office billed $26,834, Medicare allowed $6,316 and paid $5,036; for 46 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 34 | 46 | 75 | 1.04 | $26,834 | $5,036 |
| 2023 | 46 | 86 | 74 | 0.83 | $27,651 | $6,256 |
| 2022 | 19 | 23 | 73 | 0.82 | $15,750 | $2,880 |
| 2021 | 21 | 27 | 72 | 0.67 | $13,844 | $2,875 |
| 2020 | 22 | 23 | 76 | 0.84 | $8,250 | $2,943 |
| 2019 | 30 | 38 | 72 | 0.92 | $24,814 | $4,660 |
| 2018 | 25 | 26 | 75 | 1.00 | $17,000 | $3,610 |
| 2017 | 23 | 51 | 75 | 1.13 | $10,243 | $2,127 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 18 | $1,911 | $101 |
| Short return visit (20+ min) | 13 | $1,067 | $71 |
2019: 1 service
| Replacement of knee joint, both sides of knee | 15 | $2,640 | $165 |
2017: 1 service
| Short return visit (20+ min) | 12 | $471 | $36 |
Drugs they prescribed that Part D paid
$9,732
Pharmacies billed $9,732 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 19% of their Part D prescriptions (69 of 356) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 22% of their opioid prescriptions.
334 generic and 22 brand-name prescriptions · $9,732 in drug cost · 44 antibiotic prescriptions to 35 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 22 | $6,837 | $311 |
| Diclofenac Sodium Er | 20 | $675 | $34 |
| Hydrocodone-Acetaminophen | 39 | $438 | $11 |
| Meloxicam | 57 | $266 | $5 |
| Cephalexin | 30 | $250 | $8 |
See all 11 drugs
| Xarelto | 22 | $6,837 | $311 |
| Diclofenac Sodium Er | 20 | $675 | $34 |
| Hydrocodone-Acetaminophen | 39 | $438 | $11 |
| Meloxicam | 57 | $266 | $5 |
| Cephalexin | 30 | $250 | $8 |
| Ibuprofen | 50 | $238 | $5 |
| Gabapentin | 20 | $185 | $9 |
| Morphine Sulfate Er | 15 | $114 | $8 |
| Etodolac | 14 | $99 | $7 |
| Ondansetron | 27 | $58 | $2 |
| Tramadol | 12 | $6 | $0 |
Year by year
| 2024 | 356 | 103 | 19% (69) | 6% | $9,732 |
| 2023 | 188 | 77 | 15% (28) | None | $4,080 |
| 2022 | 430 | 113 | 18% (78) | 3% | $8,325 |
| 2021 | 389 | 117 | 9% (34) | None | $7,171 |
| 2020 | 287 | 91 | 15% (42) | None | $4,702 |
| 2019 | 241 | 72 | 23% (56) | 7% | $6,922 |
| 2018 | 196 | 68 | 21% (41) | 10% | $9,183 |
| 2017 | 19 | 11 | None | None | $313 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Diclofenac Sodium Er | 12 | $797 | $66 |
| Gabapentin | 23 | $209 | $9 |
| Hydrocodone-Acetaminophen | 18 | $178 | $10 |
| Meloxicam | 39 | $171 | $4 |
| Ibuprofen | 17 | $91 | $5 |
| Cephalexin | 15 | $51 | $3 |
2022: 12 drugs
| Xarelto | 13 | $4,248 | $327 |
| Gabapentin | 79 | $934 | $12 |
| Celecoxib | 15 | $490 | $33 |
| Hydrocodone-Acetaminophen | 40 | $385 | $10 |
| Meloxicam | 73 | $223 | $3 |
| Ibuprofen | 27 | $208 | $8 |
| Methylprednisolone | 19 | $155 | $8 |
| Cephalexin | 26 | $150 | $6 |
| Ondansetron | 18 | $90 | $5 |
| Tramadol | 27 | $61 | $2 |
| Amoxicillin | 14 | $35 | $3 |
| Prednisone | 11 | $26 | $2 |
2021: 11 drugs
| Diclofenac Sodium Er | 25 | $1,333 | $53 |
| Gabapentin | 76 | $670 | $9 |
| Etodolac | 11 | $426 | $39 |
| Celecoxib | 12 | $364 | $30 |
| Meloxicam | 82 | $333 | $4 |
| Ibuprofen | 21 | $239 | $11 |
| Methylprednisolone | 26 | $183 | $7 |
| Hydrocodone-Acetaminophen | 14 | $135 | $10 |
| Cephalexin | 23 | $108 | $5 |
| Ondansetron | 12 | $83 | $7 |
| Prednisone | 18 | $50 | $3 |
2020: 9 drugs
| Gabapentin | 74 | $744 | $10 |
| Diclofenac Sodium Er | 12 | $493 | $41 |
| Celecoxib | 12 | $459 | $38 |
| Hydrocodone-Acetaminophen | 22 | $240 | $11 |
| Meloxicam | 37 | $184 | $5 |
| Ibuprofen | 15 | $150 | $10 |
| Methylprednisolone | 15 | $131 | $9 |
| Tramadol | 16 | $59 | $4 |
| Amoxicillin | 16 | $54 | $3 |
2019: 6 drugs
| Celecoxib | 14 | $634 | $45 |
| Gabapentin | 37 | $402 | $11 |
| Hydrocodone-Acetaminophen | 19 | $280 | $15 |
| Meloxicam | 34 | $112 | $3 |
| Tramadol | 21 | $112 | $5 |
| Cephalexin | 15 | $77 | $5 |
2018: 4 drugs
| Gabapentin | 33 | $258 | $8 |
| Methylprednisolone | 19 | $212 | $11 |
| Meloxicam | 45 | $191 | $4 |
| Tramadol | 25 | $111 | $4 |
Money from drug and device companies
$27 in 2025
| 2025 | 1 | 1 | None | $27 |
| 2024 | 1 | 3 | None | $69 |
| 2022 | 1 | 3 | None | $1,230 |
| 2021 | 1 | 1 | None | $19 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Evolution Surgical | None | $27 | 1 payment
|
See the published payment
| Evolution Surgical | Meals · 2025-01-23 | None | $27 |
See earlier years (2024, 2022, 2021)
2024: $69
| Evolution Surgical | None | $69 | 3 payments
|
2022: $1,230
| Evolution Surgical | None | $1,230 | 3 payments
|
2021: $19
| Ethicon US | Stratafix | $19 | 1 payment
|
Professional record
- NPI
- 1851835235
- Licence
- CA 95005544
- Trained
- Johns Hopkins University School of Medicine, 2016 · 10 years ago
- Group
- Bass Medical Group
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 4626 Willow Rd Ste 200, Pleasanton, CA, 94588
- NPI first listed
- 2016-12-05
- NPI last updated
- 2024-11-12
- NPI record certified
- 2024-11-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5601 Norris Canyon Rd Ste 130, San Ramon, CA, 94583 · 2180 W Grant Line Rd Ste 100, Tracy, CA, 95377